David Chang, MASc, PhD - Chief Executive Officer
David Chang has over 15 years' experience managing SMEs, bringing products to market in the emerging field of metabolomics. He has a Masters of Applied Science at the University of Waterloo and a PhD in Chemical and Materials Engineering at the University of Alberta, where he was first involved in the early discoveries of using Nuclear Magnetic Resonance for metabolomics. He has applied his expertise in signal processing, multivariate statistics and modelling to leading-edge biomarker diagnostic applications.David also holds an appointment as an Adjunct Professor in the Faculty of Medicine at the University of Alberta. Before joining MTI in 2015, Dr. Chang was with Chenomx Inc., where he developed and managed business operations.

Haili Wang, MD - Co-Founder and Medical Director
Dr. Haili Wang is a colorectal surgeon and Assistant Professor at the University of Alberta Hospital. She also holds an MSc. in Clinical Epidemiology from the University of Alberta, where her expertise in colorectal cancer led her to the discovery of novel urine diagnostics for improved colorectal cancer screening. Dr. Wang has numerous scientific publications in the area of metabolomics and colorectal cancer surgery.
Lu Deng, PhD -  Senior Scientist and Director of Business Development, Asia
Lu Deng completed her PhD in the Department of Chemistry at the University of Alberta.  Before joining MTI, she was with The Metabolomics Innovation Centre, where she applied her expertise in metabolomics, mass spectrometry, method development and validation to biomarker discovery. Dr. Deng is the recipent of the Canadian National Research Council-IRAP Award for Commercialization for her expertise with mass-spectrometry. 
Ashley Xia, BPhm, MSc - Research Associate
Ashley Xia has more than nine years experience in analytical chemistry, specializing in mass spectrometry, metabolomics, and data analysis. She has a MSc. from the University of Alberta, and a Bachelor of Pharmacy Science from Shenyang Pharmaceutical University. Ashley previously worked at the Metabolomics Innovation Center and in QA/QC with Labs-Mart Inc., a Canadian analytical testing company. 

Jean Forsythe, BA - Manager, Corporate Development
Jean Forsythe has over fifteen years' experience in managing projects, including coordinating fundraising campaigns for university development initiatives. Before joining MTI, Jean was the Campaign Coordinator for the Hoover Institution at Stanford University. She has a BA from the University of British Columbia.

Kat Ismond, BA - Manager, Special Projects
Kat Ismond is an information specialist, with over ten years experience providing scientific writing and editing support, and experience in knowledge translation. She has a Masters degree in Library Science from the University of Alberta and a BA from Carleton University in Canada.

Gail Riehl - Administrative Assistant
Gail Riehl has over 10 years of experience as a legal assistant in insurance law. She is also an experienced event planner and organizer with various charities.
Randy Yatscoff - Board Chair
Dr. Randy Yatscoff is the former Executive Vice-President of Business Development for TEC Edmonton, a business service provider and incubator. Prior to joining TEC Edmonton, Randy was CEO and President of the drug development company Isotechnika, raising over $200M in equity financing. He has over ten years’ experience as a biotech executive. Randy was the national recipient of the 2016 Startup Canada Adam Chowaniec Lifetime Achievement Award. In an earlier lifetime, Dr. Yatscoff was an accomplished academic, a full professor and researcher at several Canadian universities. In total, he holds more than 20 patents.